IMMUNEONCO-B(01541): Nominated Liu Xiuzhi as an independent non-executive director.
Yiming Anke-B (01541) announced that Dr. Zhu Zhenping has submitted his resignation as an independent non-executive director of the company to dedicate more time to other business matters. According to the company's articles of association, Dr. Zhu will continue to fulfill his duties as an independent non-executive director until a new independent non-executive director is appointed, and his resignation will take effect from the date of the shareholders' meeting at which a new independent non-executive director is elected. After the effective date of his resignation, Dr. Zhu will no longer serve as a member of the board's audit committee, remuneration committee, and nomination committee.
IMMUNEONCO-B (01541) announced that Dr. Zhu Zhenping has submitted his resignation as the company's independent non-executive director to devote more time to other business affairs. According to the company's articles of association, Dr. Zhu will continue to fulfill his duties as an independent non-executive director until a new independent non-executive director is appointed, and his resignation will take effect from the date of the upcoming shareholders' meeting where a new independent non-executive director will be elected. After the effective date of his resignation, Dr. Zhu will no longer serve as a member of the board's audit committee, remuneration committee, and nomination committee.
After considering the recommendation from the board's nomination committee, the board has decided to nominate Dr. Liu Xiuzhi as the company's independent non-executive director. The proposed appointment of Dr. Liu is subject to approval by the shareholders at the company's general meeting by ordinary resolution.
Related Articles
BBMG (02009) announced its mid-term performance, reporting a net loss attributable to the parent company of approximately 2.172 billion yuan, an increase of 45.22% year-on-year.
CNT GROUP (00701) released its interim results, with a loss attributable to shareholders of HKD 15.663 million, narrowing by 57.1% year-on-year.
CPM GROUP (01932) released its interim results, reporting a loss attributable to shareholders of HKD 19.71 million, a year-on-year decrease of 32.4%.
BBMG (02009) announced its mid-term performance, reporting a net loss attributable to the parent company of approximately 2.172 billion yuan, an increase of 45.22% year-on-year.
CNT GROUP (00701) released its interim results, with a loss attributable to shareholders of HKD 15.663 million, narrowing by 57.1% year-on-year.
CPM GROUP (01932) released its interim results, reporting a loss attributable to shareholders of HKD 19.71 million, a year-on-year decrease of 32.4%.
RECOMMEND
